Page updated Nov. 30, 2021

COVID-19 Vaccinations

Pacific requires all students and employees to be fully vaccinated.

Pacific strongly encourages employees and students to get a vaccine booster when eligible; of particular risk are individuals in congregate settings (e.g. student housing) and those with higher risk of illness. Employees and students of Pacific who are 18 years+ and have completed their Pfizer-BioNTech or Moderna vaccine series at least six months ago are eligible for a booster dose based on current CDC and California Department of Public Health guidelines. All individuals 18 years+ who received Johnson & Johnson’s Janssen vaccine are eligible for a booster two months after their shot. Booster shots do not have to be the same brand or type as the initial vaccine(s). 

Pacific frequently hosts vaccination clinics for the community. Dates and sign-up information is available through California's MyTurn. Upcoming COVID-19 vaccination clinics are scheduled for:

Stockton (use 95211 zip code)

  • Dec. 10 | 2 p.m. to 6 p.m. | Appointments available through MyTurn beginning Nov. 26. 

San Francisco

  • Thursday, Dec. 9 | hours TBA

Pfizer Dose 1, 2, Additional and Booster will be available at Stockton and San Francisco campuses; Moderna boosters available at San Francisco clinics.

In accordance with Cal/OSHA Standards, employees must inform Pacific of their vaccine status to facilitate development of workplace protocols place prior to return.

Upload Vaccination Status

University of the Pacific Health Portal

If you have been fully vaccinated at one of Pacific’s COVID-19 vaccine clinics, we already have recorded this information in the university’s secure medical records system. You do not need to do anything at this time.

Student vaccination records are confidential and protected under FERPA.

Employee vaccination records are confidential and protected under the CMIA.

COVID-19 Vaccine Exemption

If an employee chooses to not be vaccinated, for health or religious reasons, they must complete and submit a declination form (pdf).

Employees with vaccine exemptions will be required to follow more stringent health and safety protocols specifically designed for unvaccinated individuals.

To upload declination form:


Vaccinated Outside of the United States

Individuals who were vaccinated outside the United States with a COVID-19 vaccine approval by the World Health Organization, an FDA-authorized COVID-19 vaccine and have received all the recommended doses do not need any additional doses, but may be eligible for an Additional or Booster dose based on current public health recommendations. People who received the first dose of an authorized COVID-19 vaccine that requires two doses do not need to restart the vaccine series in the United States but should receive the second dose as close to the recommended time as possible.

Some people may have received a COVID-19 vaccine that is not currently authorized in the United States. No data are available on the safety or efficacy of receiving a COVID-19 vaccine currently authorized in the United States after receipt of a non-FDA-authorized COVID-19 vaccine. However, in some circumstances people who received a COVID-19 vaccine not currently authorized in the United States may be offered revaccination with an FDA-authorized vaccine:

WHO has listed the following COVID-19 vaccines for emergency use*:

  • Pfizer-BioNTech COVID-19 Vaccines (e.g., BNT162b2, COMIRNATY, Tozinameran)
  • AstraZeneca-Oxford COVID-19 Vaccines (e.g., [ChAdOx1-S (recombinant)], AZD1222, Covishield, Vaxzevria)
  • Janssen (Johnson & Johnson) COVID-19 Vaccine (e.g., Ad26.COV2.S)
  • Moderna COVID-19 Vaccine (e.g., mRNA 1273, Takeda, Spikevax)
  • Sinopharm-BIBP COVID-19 Vaccine
  • Sinovac-CoronaVac COVID-19 Vaccine
  • Bharat Biotech International COVID-19 Vaccines (e.g., BBV152, COVAXIN)

*As of Nov. 22, 2021. Due to frequent updates newly approved vaccines may not be listed.

The minimum interval between the last dose of a non-FDA authorized vaccine or a WHO-listed vaccine and an FDA-authorized COVID-19 vaccine is 28 days. Only people who have received all recommended doses of an FDA-authorized or WHO-listed COVID-19 vaccine are considered fully vaccinated for the purpose of public health guidance.


Pacific's Use of Your Vaccination Status

Individuals are not allowed to inquire about the vaccination status of others at the University. However, in some instances Pacific employees may need to know the status of others in order to support and adhere to health and safety measures. This information will be provided by HR to individuals identified as needing to know, based on their role.

If you have not been so notified but feel you need access to this information, you may submit a Designation as Need-to-Know for COVID-19 Vaccination Status form (pdf). Please complete and submit to Human Resources for review.

Vaccination FAQs

For additional information please visit the CDC's guidance on COVID-19 vaccinations

Yes. COVID-19 vaccines are working well to prevent severe illness, hospitalization, and death, even against the widely circulating Delta variant. However, public health experts are starting to see reduced protection, especially among certain populations, against mild and moderate disease. (Source)

It can be difficult to know which sources of information you can trust. Learn more about finding credible vaccine information

No. None of the authorized and recommended COVID-19 vaccines or COVID-19 vaccines currently in development in the United States contain the live virus that causes COVID-19. This means that a COVID-19 vaccine cannot make you sick with COVID-19.

No. Neither the recently authorized and recommended vaccines nor the other COVID-19 vaccines currently in clinical trials in the United States can cause you to test positive on viral tests, which are used to see if you have a current infection.

If your body develops an immune response—the goal of vaccination—there is a possibility you may test positive on some antibody tests. Antibody tests indicate you had a previous infection and that you may have some level of protection against the virus. Experts are currently looking at how COVID-19 vaccination may affect antibody testing results.

The three COVID-19 vaccines currently available in the United States do not contain eggs, preservatives, or latex. For a full list of ingredients, please see each vaccine’s Fact Sheet for Recipients and Caregivers:

Yes. Due to the severe health risks associated with COVID-19 and the fact that reinfection with COVID-19 is possible, you should be vaccinated regardless of whether you already had COVID-19 infection. If you were treated for COVID-19 symptoms with monoclonal antibodies or convalescent plasma, you should wait 90 days before getting a COVID-19 vaccine. Talk to your doctor if you are unsure what treatments you received or if you have more questions about getting a COVID-19 vaccine.

Experts do not yet know how long someone is protected from getting sick again after recovering from COVID-19. The immunity someone gains from having an infection, called “natural immunity,” varies from person to person.  It is rare for someone who has had COVID-19 to get infected again. It also is uncommon for people who do get COVID-19 again to get it within 90 days of when they recovered from their first infection.  We won’t know how long immunity produced by vaccination lasts until we have more data on how well the vaccines work.

Both natural immunity and vaccine-induced immunity are important aspects of COVID-19 that experts are working to learn more about, and CDC will keep the public informed as new evidence becomes available.

Per the CDC, COVID-19 vaccines can be administered at the same time as other vaccinations and a waiting period is no longer required. Questions about individual medical circumstances should be directed to your healthcare provider.

All the COVID-19 vaccines being used have gone through rigorous studies to ensure they are as safe as possible. Systems that allow CDC to watch for safety issues are in place across the entire country.

The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorizations for COVID-19 vaccines that have been shown to meet rigorous safety criteria and be effective as determined by data from the manufacturers and findings from large clinical trials. Watch a video describing the emergency use authorization. Clinical trials for all vaccines must first show they meet rigorous criteria for safety and effectiveness before any vaccine, including COVID-19 vaccines, can be authorized or approved for use. The known and potential benefits of a COVID-19 vaccine must outweigh the known and potential risks of the vaccine.

People with underlying medical conditions should consult with their healthcare provider to assist in making a decision about the COVID-19 vaccine.

Serious problems from vaccination can happen, but they are rare. CDC has learned of reports that some people have experienced severe allergic reactions—also known as anaphylaxis—after getting a COVID-19 vaccine. As an example, an allergic reaction is considered severe when a person needs to be treated with epinephrine or EpiPen© or if they must go to the hospital. Learn more about COVID-19 vaccines and allergies